Compound Detail
CHEMBL413434
OREXIN B Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O
Basic Information
| ChEMBL ID | CHEMBL413434 |
| Name | OREXIN B |
| Phase | Preclinical |
| Structure Type | BOTH |
| InChI Key | OHOWSYIKESXDMN-WMQZXSDYSA-N |
3
Targets
8
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
2899.4
MW (Da)
Drug Information
| Molecule Type | Protein |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 8 meas. best 10.09
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Orexin receptor type 2 CHEMBL4792 | EC50 | 10.09 | 9.1333 | 0.1 | 3 |
| Orexin/Hypocretin receptor type 1 CHEMBL5113 | EC50 | 9.08 | 7.92 | 0.8 | 3 |
| Unchecked CHEMBL612545 | EC50 | 8.0 | 8.0 | 10.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Orexin receptor type 2 | EC50 | = | 0.081 | nM | 10.09 | Agonist activity against human orexin 2 receptor; EC50; nM | 12467628 |
| Orexin receptor type 2 | EC50 | = | 0.081 | nM | 10.09 | Agonist activity against human orexin 2 receptor; EC50; nM | 12467628 |
| Orexin/Hypocretin receptor type 1 | EC50 | = | 0.83 | nM | 9.08 | Agonist activity against human orexin 1 receptor; EC50; nM | 12467628 |
| Orexin/Hypocretin receptor type 1 | EC50 | = | 0.83 | nM | 9.08 | Agonist activity against human orexin 1 receptor; EC50; nM | 12467628 |
| Unchecked | EC50 | = | 10.0 | nM | 8.0 | Agonist selectivity for orexin receptor 1 versus orexin receptor 2 | 12467628 |
| Unchecked | EC50 | = | 10.0 | nM | 8.0 | Agonist selectivity for orexin receptor 1 versus orexin receptor 2 | 12467628 |
| Orexin receptor type 2 | EC50 | = | 60.0 | nM | 7.22 | Agonist activity at OX2R (unknown origin) | 35051577 |
| Orexin/Hypocretin receptor type 1 | EC50 | = | 2500.0 | nM | 5.6 | Agonist activity at OX1R (unknown origin) | 35051577 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12467628 | 10.1016/s0960-894x(02)00851-x | Orexin/Hypocretin receptor type 1 | 3 |
| 12467628 | 10.1016/s0960-894x(02)00851-x | Orexin receptor type 2 | 3 |
| 12467628 | 10.1016/s0960-894x(02)00851-x | Unchecked | 3 |
| 35051577 | 10.1016/j.bmcl.2022.128555 | Orexin/Hypocretin receptor type 1 | 1 |
| 35051577 | 10.1016/j.bmcl.2022.128555 | Orexin receptor type 2 | 1 |
| 35051577 | 10.1016/j.bmcl.2022.128555 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine